Dr. Simo Schwartz Jr. has been selected as a member of the European Medicines Agency's Nanomedicine Expert Working Group

The researcher and strategic director of the Biobank and Biomodel at Vall d'Hebron Barcelona Campus Hospital will help create guidelines to regulate the development of new therapies and technologies in this area.

05/04/2023

Dr. Simo Schwartz Jr, principal investigator of the Pharmacological Targeting and Release group at Vall d'Hebron Research Institute (VHIR) and strategic director of the Biobank and Biomodel at Vall d'Hebron Barcelona Campus Hospital, has been selected as a member of one of the European Medicines Agency (EMA) Operational Expert Groups. Specifically, the group of experts that assists the Working Group on New Therapies and Technologies in Nanomedicines of the EMA (NTWP Operational Expert Group on nanomedicines).

The objective of this advisory committee is to support the development of guidelines to technically and legally regulate the creation of new therapies and technologies in the area of nanomedicine. The group is currently working on the development of a guideline on the treatment and development of nanomedicines with non-biodegradable parts. Dr. Schwartz Jr. is a leading international scientist in this field with extensive professional experience in the sector. He currently serves as president of the European Association of Nanomedicine.

Share it:

Related news

Related professionals

Subscribe to our newsletters and be a part of Vall d'Hebron Campus

The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”.
Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health).
Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information.
Legal basis: Consent of the data subject.
Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen.
Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time.
Source: The data subject.
Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.